Merck gets positive EU CHMP opinion for Keytruda as adjuvant treatment for adults with Non-Small Cell Lung Cancer Ruchika Sharma18 Sep 2023 6:00 AM GMTRahway: Merck, known as MSD outside of the United States and Canada, has announced that the European Medicines Agency’s Committee for Medicinal...
Gilead Sciences Trodelvy, Keytruda combo study demonstrates promising clinical activity in first-line Metastatic Non-Small Cell Lung Cancer Ruchika Sharma12 Sep 2023 9:00 AM GMTFoster City: Gilead Sciences, Inc. has announced promising early data from the global, open-label, Phase 2 EVOKE-02 study evaluating Trodelvy...
Merck, Portage Biotech collaborate to evaluate Portage's next-generation adenosine antagonists in combination with Keytruda in solid tumors Ruchika Sharma10 Sep 2023 6:00 AM GMTWestport: Portage Biotech Inc., a clinical-stage immuno-oncology company advancing novel multi-targeted therapies for use as monotherapy and in...
Rare case of Lichen Planus in patient on Pembrolizumab reported Medha Baranwal2 July 2023 2:30 PM GMTPunjab: A recent case study published in Indian Dermatology Online Journal described developing a rare immune-related adverse side effect in a patient...
USFDA accepts application for Merck KEYTRUDA plus chemotherapy as treatment for Biliary Tract Cancer Ruchika Sharma9 Jun 2023 12:00 PM GMTRahway: Merck, known as MSD outside of the United States and Canada, has announced the U.S. Food and Drug Administration (FDA) has accepted for review...
MSD Pharma Gets CDSCO Panel Nod for additional indication of anticancer drug Pembrolizumab Dr. Divya Colin23 May 2023 12:30 PM GMTNew Delhi: Based on the global clinical trial data presented by drug major, MSD Pharmaceuticals, the Subject Expert Committee (SEC) functional under...
Desmoplastic melanoma patients respond "exceptionally" well to treatment with immunotherapy alone Dr. Kamal Kant Kohli5 May 2023 2:30 PM GMTUSA: A recent study has suggested that many patients with desmoplastic melanoma could avoid the risk of toxicity from combination therapies and...
Pembrolizumab effective as post-nephrectomy adjuvant therapy in clear cell renal cell carcinoma: LANCET Dr.Niharika Harsha B12 April 2023 4:00 AM GMTUpdated results from the KEYNOTE-564 trial showed that pembrolizumab monotherapy can be used as a standard of care for patients with renal...
Import duty exempted on all drugs, food for special medical purposes for personal use to treat rare diseases Ruchika Sharma31 March 2023 7:33 AM GMTNew Delhi: The government has exempted basic customs duty on all drugs and food for special medical purposes imported for personal use for treatment...
Immunotherapy before surgery significantly improves outcomes of patients with melanoma: NEJM Dr. Kamal Kant Kohli10 March 2023 4:30 AM GMTUCLA Jonsson Comprehensive Cancer Center researchers have found in a multicenter trial that Immunotherapy before surgery significantly improves...
Merck scraps another prostate cancer study as Keytruda therapy disappoints Ruchika Sharma1 March 2023 8:45 AM GMTNew Delhi: Merck & Co said on Tuesday it will stop a late-stage trial evaluating a combination therapy with its cancer drug Keytruda after interim...
Wellmarker Bio enters clinical trial collaboration with MSD to evaluate WM-A1-3389 in combination with KEYTRUDA Ruchika Sharma9 Feb 2023 8:45 AM GMTWM-A1-3389 is a novel therapeutic antibody targeting a new immune checkpoint protein discovered by Wellmarker Bio and has demonstrated efficacy across...
